Technical Analysis for TSSNF - Tissue Regenix Group Plc

Grade Last Price % Change Price Change
grade F 0.01 -28.57% -0.0040
TSSNF closed down 28.57 percent on Thursday, April 9, 2020, on 58 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical TSSNF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -28.57%
Gapped Up Strength -28.57%
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Older signals for TSSNF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and Cardiac divisions. The company's decellularisation (dCELL) technology removes DNA and other cellular material from animal and human tissue leaving intact an inert acellular matrix upon which the patient's cells can repopulate. Its dCELL technology has applications in various clinical needs, such as wound care, and heart valve replacement. It offers DermaPure used for the treatment and management of complex and chronic wounds; and SurgiPure XD for the repair of hernias and/or body wall defects, which require the use of reinforcing or buttressing material to obtain the desired surgical outcome. The company is also developing OrthoPure XM, which makes the implant biocompatible and provides a biomechanically appropriate scaffold for cellular repopulation and eventual regeneration in the partial meniscectomy; OrthoPure XT and OrthoPure HT used for the anterior cruciate ligament injuries; and CardioPure for the replacement of human aortic and pulmonary valves. Tissue Regenix Group plc was incorporated in 2006 and is based in Leeds, the United Kingdom.
Medicine Medical Specialties Surgery Medical Technology Regenerative Medicine Biomaterials Prosthetics Tissue Engineering Chronic Wounds Platform Technologies Biomedical Engineering Implant

Is TSSNF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.145
52 Week Low 0.01
Average Volume 4,308
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.0000
10-Day Moving Average 0.0459
Average True Range 0.0136
ADX 0.0
+DI 25.4613
-DI 77.0163
Chandelier Exit (Long, 3 ATRs ) 0.1042
Chandelier Exit (Short, 3 ATRs ) 0.0508
Upper Bollinger Band 0.0000
Lower Bollinger Band 0.0000
Percent B (%b) 0.0
BandWidth 0.0000
MACD Line -0.0165
MACD Signal Line -0.0071
MACD Histogram -0.0095
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0100
Resistance 3 (R3) 0.0100 0.0100 0.0100
Resistance 2 (R2) 0.0100 0.0100 0.0100 0.0100
Resistance 1 (R1) 0.0100 0.0100 0.0100 0.0100 0.0100
Pivot Point 0.0100 0.0100 0.0100 0.0100 0.0100
Support 1 (S1) 0.0100 0.0100 0.0100 0.0100 0.0100
Support 2 (S2) 0.0100 0.0100 0.0100 0.0100
Support 3 (S3) 0.0100 0.0100 0.0100
Support 4 (S4) 0.0100